A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Year to date metric has recorded a gain of 35.82%.However, over the last six months, we can see a weaker performance of 169.25%. Over the last 30 days, the price of WGS has fallen by 2.77%. And in the last five days, it has surged by 6.01%.
GeneDx Holdings Corp’s stock has had a calm market performance. The 1-year high for the company’s stock was $115.60 on 02/19/25, and the lowest price during the same period was recorded at $8.10 on 03/25/24.
52-week price history of WGS Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. GeneDx Holdings Corp’s current trading price is -9.70% away from its 52-week high, while its distance from the 52-week low is 1188.77%. The stock’s price range over this timeframe has been between $8.10 and $115.60. The shares of the Healthcare sector company recorded a trading volume of approximately 0.7 million for the day, which was comparatively lower than the average daily volume of 1.02 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
GeneDx Holdings Corp (WGS) has experienced a quarterly rise of 31.81% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.93B and boasts a workforce of 1000 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 81.10, with a change in price of +45.30. Similarly, GeneDx Holdings Corp recorded 881,658 in trading volume during the last 100 days, posting a change of +76.66%.
WGS’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for WGS stands at 0.48. Similarly, the long-term debt-to-equity ratio is also 0.46.
WGS Stock Stochastic Average
GeneDx Holdings Corp’s raw stochastic average for the past 50 days is currently at 80.33%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 88.59%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 63.17% and 44.38%, respectively.
